{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:55:48Z","timestamp":1790207748615,"version":"4.1.0"},"reference-count":16,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017655","name":"Incyte Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chemotherapy"],"published-print":{"date-parts":[[2026,4,3]]},"DOI":"10.1080\/1120009x.2025.2497641","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T09:09:30Z","timestamp":1745917770000},"page":"302-308","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Exposure-response analyses of pemigatinib in patients with myeloid\/lymphoid neoplasms with fibroblast growth factor receptor 1 rearrangement"],"prefix":"10.1080","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3437-4399","authenticated-orcid":false,"given":"Xiaohua","family":"Gong","sequence":"first","affiliation":[{"name":"Incyte Corporation","place":["Wilmington, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Akil","sequence":"additional","affiliation":[{"name":"Certara","place":["Radnor, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Grinshpun","sequence":"additional","affiliation":[{"name":"Certara","place":["Radnor, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Francis","sequence":"additional","affiliation":[{"name":"Certara","place":["Radnor, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Khusial","sequence":"additional","affiliation":[{"name":"Certara","place":["Radnor, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Incyte Corporation","place":["Wilmington, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Zhen","sequence":"additional","affiliation":[{"name":"Incyte Corporation","place":["Wilmington, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lovern","sequence":"additional","affiliation":[{"name":"Certara","place":["Radnor, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Chen","sequence":"additional","affiliation":[{"name":"Incyte Corporation","place":["Wilmington, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2009.11.003"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2022.03.008"},{"key":"e_1_3_5_4_1","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines\u00ae) for myeloid\/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions version 2. All rights reserved; 2024 (cited 2025 Feb 3). Available from: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1505."},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0404438101"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/15513819709168354"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2006.04.015"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.2812.2812"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2021.30"},{"key":"e_1_3_5_11_1","volume-title":"Full prescribing information","author":"PEMAZYRE\u00ae (pemigatinib)","year":"2022","unstructured":"PEMAZYRE\u00ae (pemigatinib). Full prescribing information. Wilmington, DE, USA: Incyte Corporation; 2022."},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.13064"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.02.001"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-148103"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.103091"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12805"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-180945"}],"container-title":["Journal of Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1120009X.2025.2497641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:43:25Z","timestamp":1776663805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1120009X.2025.2497641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4,3]]}},"alternative-id":["10.1080\/1120009X.2025.2497641"],"URL":"https:\/\/doi.org\/10.1080\/1120009x.2025.2497641","relation":{},"ISSN":["1120-009X","1973-9478"],"issn-type":[{"value":"1120-009X","type":"print"},{"value":"1973-9478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yjoc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yjoc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-12-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}